A 23-gene multi-omics signature predicts prognosis and treatment response in non-small cell lung cancer
Abstract Background We developed the first multi-omics prognostic signature integrating 19 programmed cell death (PCD) pathways and organelle functions (mitochondria, lysosomes, Golgi apparatus) to predict prognosis and immunotherapy response in non-small cell lung cancer (NSCLC). (2) Methods: By co...
Saved in:
| Main Authors: | Yinxu Zhang, Siwang Wang, Xiaoyang Chen, Guangyu Zhang, Yuxi Wang, Xiaomei Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03243-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma
by: Yang Ding, et al.
Published: (2025-04-01) -
Corrigendum: Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma
by: Yang Ding, et al.
Published: (2025-04-01) -
The role of PSMC4 in non-small cell lung cancer: implications for prognosis, diagnosis, and immune microenvironment modulation
by: Lili Zhu, et al.
Published: (2025-05-01) -
Neoantigen load as a predictor of relapse in early-stage NSCLC: features that agonise and antagonise prognosis
by: Linda Ye, et al.
Published: (2025-08-01) -
Combined small-cell lung cancer with adenocarcinoma: a rare case and literatures review
by: Xiao Wu, et al.
Published: (2025-08-01)